Gylden Pharma Limited
PrivateLast Round
Grant
Nov 17, 2023
Total Funding Raised
$14.53M
Company Overview
Gylden Pharma Limited operates in Healthcare & Life Sciences and is based in Abingdon. Its latest recorded funding round was a Grant round in November 2023.
Gylden Pharma Limited is a clinical-stage biotechnology company that develops synthetic T cell-priming vaccines and immunotherapies for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gylden Pharma Limited Comparables
Compare Gylden Pharma Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verndari, Inc. | 81% | |
| Uvax Bio, LLC | 79% | |
| Micron Biomedical | 77% |
For institutional investors. Book with your work email.
Gylden Pharma Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 17, 2023 | ||||
| VC Round | Jun 20, 2023 | ||||
| Grant | Feb 22, 2022 | ||||
| VC Round | Nov 18, 2020 | ||||
| Series A | Jan 9, 2020 | ||||
Grant | Apr 5, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gylden Pharma Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Department of Health and Social Care | Grant |
| Innovate UK | Grant |
| Vickers Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 195% MoM.
- Jun 20, 2023
Molecular Biology Institute of Paraná participated in the round.
For institutional investors. Book with your work email.
Gylden Pharma Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gylden Pharma Limited's valuation, stock price, and market status.
Is Gylden Pharma Limited a public or private company?
Gylden Pharma Limited is a private company.
What is the current stock price of Gylden Pharma Limited?
Gylden Pharma Limited is a private company, so its shares have no public market price. Caplight tracks Gylden Pharma Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gylden Pharma Limited worth (valuation)?
Valuation information for Gylden Pharma Limited is not publicly available.
Can I buy Gylden Pharma Limited stock?
Gylden Pharma Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gylden Pharma Limited's last funding round?
Gylden Pharma Limited's most recent funding round was Grant on November 17, 2023.
Who are the main investors in Gylden Pharma Limited?
Key investors in Gylden Pharma Limited include Vickers Venture Partners.
Will Gylden Pharma Limited IPO soon?
No public IPO plans have been announced for Gylden Pharma Limited.
How can I track Gylden Pharma Limited secondary market activity?
Caplight tracks bids, offers, and trades in Gylden Pharma Limited's shares on secondary markets.